Esperion Therapeutics
ESPR
#6169
Rank
ยฃ0.66 B
Marketcap
ยฃ2.80
Share price
-1.58%
Change (1 day)
2.50%
Change (1 year)

Revenue for Esperion Therapeutics (ESPR)

Revenue in 2025 (TTM): ยฃ0.23 Billion

According to Esperion Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.22 Billion. In 2024 the company made a revenue of ยฃ0.26 Billion an increase over the revenue in the year 2023 that were of ยฃ91.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Esperion Therapeutics from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.23 B-13.02%
2024 ยฃ0.26 B190%
2023 ยฃ91.31 M46.37%
2022 ยฃ62.38 M7.35%
2021 ยฃ58.11 M-65.19%
2020 ยฃ0.16 B47.55%
2019 ยฃ0.11 B
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2000 ยฃ0 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ0.47 B 107.57%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.32 B 918.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 20,566.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ10.68 B 4,589.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
ยฃ0.44 B 97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
ยฃ53.15 M-76.67%๐Ÿ‡บ๐Ÿ‡ธ USA